Park, M.; Suh, J.K.; Lee, J.A.; Park, H.J.; Park, E.Y.; Yoo, C.W.; Lim, M.C.; Park, S.-Y.; Park, B.K.
Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin. Cancers 2023, 15, 5290.
https://doi.org/10.3390/cancers15215290
AMA Style
Park M, Suh JK, Lee JA, Park HJ, Park EY, Yoo CW, Lim MC, Park S-Y, Park BK.
Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin. Cancers. 2023; 15(21):5290.
https://doi.org/10.3390/cancers15215290
Chicago/Turabian Style
Park, Meerim, Jin Kyung Suh, Jun Ah Lee, Hyeon Jin Park, Eun Young Park, Chong Woo Yoo, Myong Cheol Lim, Sang-Yoon Park, and Byung Kiu Park.
2023. "Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin" Cancers 15, no. 21: 5290.
https://doi.org/10.3390/cancers15215290
APA Style
Park, M., Suh, J. K., Lee, J. A., Park, H. J., Park, E. Y., Yoo, C. W., Lim, M. C., Park, S. -Y., & Park, B. K.
(2023). Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin. Cancers, 15(21), 5290.
https://doi.org/10.3390/cancers15215290